Total planned funding: $238,462,329
Clear active filters
Implementing Agency
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| South Africa | $60,984,503 |
| Uganda | $34,147,247 |
| Zimbabwe | $26,083,751 |
| Nigeria | $19,305,419 |
| Zambia | $18,447,309 |
| Côte d'Ivoire | $11,497,071 |
| Ethiopia | $11,144,735 |
| Tanzania | $11,060,623 |
| Kenya | $9,457,688 |
| Mozambique | $7,680,467 |
| Cameroon | $6,460,175 |
| Dominican Republic | $5,802,366 |
| Malawi | $4,900,000 |
| Lesotho | $3,572,811 |
| Ghana | $2,173,000 |
| Guyana | $1,900,000 |
| Caribbean Region | $1,470,000 |
| Vietnam | $1,009,699 |
| Botswana | $616,000 |
| Indonesia | $500,000 |
| Cambodia | $149,465 |
| Ukraine | $100,000 |
| Namibia | $0 |
| Angola | $0 |
| Eswatini | $0 |
Organizational Types
| Implementing Agency | $238,462,329 |
Program Areas
| Treatment | $70,271,059 |
| Care | $69,140,229 |
| Prevention | $59,173,467 |
| Governance and Systems | $27,968,897 |
| Testing | $11,908,679 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $62,615,532 |
| HKID: Care: Orphans and Vulnerable Children | $24,560,238 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $23,109,055 |
| HBHC: Care: Adult Care and Support | $21,571,696 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $18,828,250 |
| HVTB: Care: TB/HIV | $18,499,836 |
| HVCT: Testing: HIV Testing and Counseling | $11,908,679 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,324,855 |
| HLAB: Laboratory Infrastructure | $10,581,038 |
| HVSI: Strategic Information | $10,411,593 |
| PDTX: Treatment: Pediatric Treatment | $7,655,527 |
| OHSS: Health Systems Strengthening | $6,976,266 |
| PDCS: Care: Pediatric Care and Support | $4,508,459 |
| HMBL: Biomedical Prevention: Blood Safety | $3,380,854 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,583,407 |
| HMIN: Biomedical Prevention: Injection Safety | $797,046 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $150,000 |
| HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
University of the Witwatersrand:
$27,217,584
View countries